Afatinib in NSCLC With HER2 Mutation

Clinical trial NCT02597946 · COMPLETED

Trial details

NCT number: NCT02597946
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2016-03-18
Primary completion: 2018-07-22
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.